致病蛋白质图谱有助诊断多种神经退行性疾病

Core Insights - A research team in the U.S. has created a comprehensive map of pathogenic tau proteins, identifying unique characteristics of tau protein molecules in various neurodegenerative diseases, which will aid in early diagnosis and drug development [1][2] Group 1: Research Findings - The study analyzed brain tissue samples from over 200 individuals, including patients with tau-related neurodegenerative diseases, patients with dementia not caused by tau proteins, and healthy individuals [1] - Researchers identified 145 modification sites and 195 cleavage sites in tau proteins associated with diseases, revealing distinct molecular characteristics corresponding to different diseases [1] Group 2: Clinical Implications - Approximately 20 tau-related neurodegenerative diseases have been identified, sharing clinical symptoms such as brain atrophy and cognitive dysfunction, ultimately leading to dementia [2] - Previous technologies struggled to effectively detect and differentiate between various tau-related neurodegenerative diseases, hindering early diagnosis, drug development, and clinical trials [2] - The research provides potential diagnostic biomarkers and drug targets, which are crucial for the classification, diagnosis, and treatment of related diseases [2]